12:00 AM
Jul 20, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Florpiramine: Preliminary Phase II data

Preliminary data from a blinded Phase II trial showed that mean retention of florpiramine in cortical gray matter differed significantly between elderly subjects with normal cognitive (NC) function and those diagnosed with...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >